Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yinyi Yu

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Plos One|April 5, 2019
Correlation between herpes simplex virus neutralizing antibody titers determined by ELVIS cell and traditional plaque reduction assaysTamara P Blevins, Yinyi Yu, Robert B Belshe, et al.
Vaccines|May 28, 2025
Differences in Mpox and Vaccinia Immunity Induced by Non-Replicating and Replicating Vaccinia-Based VaccinesGetahun Abate, Krystal Meza, Yinyi Yu, et al.
Plos One|December 15, 2015
Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex VirusesTamara P Blevins, Michelle C Mitchell, Maria Korom, et al.
The Journal of Infectious Diseases|February 24, 2022
Neutralizing Antibody Kinetics and Immune Protection Against Herpes Simplex Virus 1 Genital Disease in Vaccinated WomenRobert B Belshe, Tamara P Blevins, Yinyi Yu, et al.
Vaccines|January 24, 2025
Optimizing Microneutralization and IFN-γ ELISPOT Assays to Evaluate Mpox ImmunityYinyi Yu, Krystal Meza, Chase Colbert, et al.
Clinical Immunology (Orlando, Fla.)|April 13, 2013
An altered relationship of influenza vaccine-specific IgG responses with T cell immunity occurs with aging in humansKi Soo Kang, Naeun Lee, Min Sun Shin, et al.
Clinical and Vaccine Immunology : CVI|November 17, 2016
Comparisons of the Humoral and Cellular Immune Responses Induced by Live Attenuated Influenza Vaccine and Inactivated Influenza Vaccine in AdultsDaniel F Hoft, Kathleen R Lottenbach, Azra Blazevic, et al.
Vaccine|August 7, 2013
A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspASharon E Frey, Kathleen R Lottenbach, Heather Hill, et al.
ACS Infectious Diseases|May 22, 2025
Antiviral Activity of the Acyclic Nucleoside Phosphonate Prodrug LAVR-289 against Poxviruses and African Swine Fever VirusElie Marcheteau, Estelle Mosca, Gaelle Frenois-Veyrat, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Plos One|April 5, 2019
Correlation between herpes simplex virus neutralizing antibody titers determined by ELVIS cell and traditional plaque reduction assaysTamara P Blevins, Yinyi Yu, Robert B Belshe, et al.
Vaccines|May 28, 2025
Differences in Mpox and Vaccinia Immunity Induced by Non-Replicating and Replicating Vaccinia-Based VaccinesGetahun Abate, Krystal Meza, Yinyi Yu, et al.
Plos One|December 15, 2015
Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex VirusesTamara P Blevins, Michelle C Mitchell, Maria Korom, et al.
The Journal of Infectious Diseases|February 24, 2022
Neutralizing Antibody Kinetics and Immune Protection Against Herpes Simplex Virus 1 Genital Disease in Vaccinated WomenRobert B Belshe, Tamara P Blevins, Yinyi Yu, et al.
Vaccines|January 24, 2025
Optimizing Microneutralization and IFN-γ ELISPOT Assays to Evaluate Mpox ImmunityYinyi Yu, Krystal Meza, Chase Colbert, et al.
Clinical Immunology (Orlando, Fla.)|April 13, 2013
An altered relationship of influenza vaccine-specific IgG responses with T cell immunity occurs with aging in humansKi Soo Kang, Naeun Lee, Min Sun Shin, et al.
Clinical and Vaccine Immunology : CVI|November 17, 2016
Comparisons of the Humoral and Cellular Immune Responses Induced by Live Attenuated Influenza Vaccine and Inactivated Influenza Vaccine in AdultsDaniel F Hoft, Kathleen R Lottenbach, Azra Blazevic, et al.
Vaccine|August 7, 2013
A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspASharon E Frey, Kathleen R Lottenbach, Heather Hill, et al.
ACS Infectious Diseases|May 22, 2025
Antiviral Activity of the Acyclic Nucleoside Phosphonate Prodrug LAVR-289 against Poxviruses and African Swine Fever VirusElie Marcheteau, Estelle Mosca, Gaelle Frenois-Veyrat, et al.
Pageof 1